Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications

Clinical trials for MET inhibitors have demonstrated limited success for their use in colon cancer (CC). However, clinical efficacy may be obscured by a lack of standardisation in MET assessment for patient stratification. In this study, we aimed to determine the molecular context in which MET is de...

Descripción completa

Detalles Bibliográficos
Autores principales: Craig, Stephanie G., Mende, Svenja, Humphries, Matthew P., Bingham, Victoria, Viratham Pulsawatdi, Amélie, Loughrey, Maurice B., Coleman, Helen G., McQuaid, Stephen, Wilson, Richard H., Van Schaeybroeck, Sandra, James, Jacqueline A., Salto‐Tellez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637556/
https://www.ncbi.nlm.nih.gov/pubmed/34428346
http://dx.doi.org/10.1002/1878-0261.13089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637556/
https://www.ncbi.nlm.nih.gov/pubmed/34428346
http://dx.doi.org/10.1002/1878-0261.13089

Ejemplares similares